Molecule known to slow inflammation linked to scleroderma, could be treatment target
A molecule that was until recently known as a brake on inflammation has now been implicated in fibrosis in scleroderma patients.
Jan 31, 2023
0
36
A molecule that was until recently known as a brake on inflammation has now been implicated in fibrosis in scleroderma patients.
Jan 31, 2023
0
36
Researchers have uncovered cancer-like genetic mutations in the affected cells of people with scleroderma, pointing the way to potential new ways to treat the debilitating and sometimes fatal skin and connective tissue disease.
Oct 20, 2022
0
15
A substance produced by gut microorganisms can lead to scarring and blood vessel damage in patients with scleroderma, a new study suggests.
Aug 24, 2022
0
36
Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, an incurable and life-threatening autoimmune disease, a new study shows.
May 9, 2022
0
15
A Michigan Medicine-led study found that patients in the United States with a rare form of scleroderma have a greater chance of dying from related kidney, heart and lung problems, despite taking medications used to treat ...
Oct 26, 2021
0
3
Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma.
Aug 3, 2021
0
111
People with a rare autoimmune disease, who likely experience more serious isolation during a global pandemic, saw their anxiety and depression improve after receiving online mental health intervention through an international ...
Jun 16, 2021
0
4
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon—thanks to a computer algorithm—become even more accurate.
Apr 21, 2021
0
10
Scleroderma, a chronic and currently incurable orphan disease where tissue injury causes potentially lethal skin and lung scarring, remains poorly understood.
Jan 19, 2021
0
16
Like many autoimmune diseases, systemic sclerosis, or scleroderma, can be a challenge to diagnose because its symptoms are varied, can range from mild to debilitating, and often resemble those of other conditions, such as ...
Jul 16, 2020
0
1